期刊文献+

一个细胞融合实验体系的建立及初步应用 被引量:1

Construction of a cell-cell fusion system and its primary application
下载PDF
导出
摘要 目的建立一个细胞融合实验体系,观察凝血酶(thrombin,Th)对Ⅰ型人免疫缺陷病毒(human immunodeficiency virus typeⅠ,HIV-1)包膜糖蛋白(envelope glycoproteins,Env)介导的细胞融合的影响。方法采用携带HIV-1 JRFL株env基因的表达质粒pSV-Ⅲ-JRFL-dCT与携带HIV-1 tat基因的表达质粒pcTat共转染293T细胞,检测到细胞膜表面Env表达后。将pSV-Ⅲ-JRFL-dCT与pcTat分别按1:2、2:3、1:1、2:1、5:1、10:1共转染293T细胞,然后再与Magic 5A细胞进行融合实验,计数融合细胞数目并确定最适宜的融合条件,建立稳定的细胞-细胞融合实验体系。在所建立融合体系基础上利用Th处理Env表达细胞,观察对融合作用的影响。结果pSV-Ⅲ-JRFL-dCT与pcTat按1:1、2:1共转染293T细胞,可建立稳定的细胞-细胞融合实验体系。Th能够增强细胞融合,且融合细胞数随着Th浓度增高而逐渐增加。Th处理10 min与处理30 min比较,融合增强作用更加显著。结论质粒pSV-Ⅲ-JRFL-dCT与pcTat按1:1、2:1共转染293T细胞,与Magic5A细胞进行融合实验可得到稳定的细胞-细胞融合实验体系,Th对HIV-1包膜介导的细胞融合有促进作用。 Objective To construct a cell-cell fusion system and to examine the effect of thrombin on fusion mediated by Human immunodeficiency virus type Ⅰ (HIV-1) envelope glycoproteins (Env). Methods 293T cells were cotransfected with HIV-1 Env expression plasmid psv-Ⅲ-JRFL-dCT and Tat expression plasmid pcTat. The transfected cells were harvested at different time and HIV-1 Env proteins expressed on the surface of 293T cells were detected by flow cytometry. Then the 293T cells expressing Env proteins were cocuhured with Magic5A cells for 20 h. Fused cells were stained by X-gal as blue cells and were examined by microscopy. When a stable fusion system was constructed, the 293T cells were treated by thrombin and the effect of thrombin was examined by counting the fused cells. Results The cotransfection with psv-Ⅲ-JRFL-dCT and pcTat at 1 : 1 and 2: 1 could render a stable fusion system. After the treatment on 293T cells expressing Env, Th promoted the fusion effect in a time-dependent manner. Conclusions Via coculturing 293T cells cotransfected with psv-m-JRFL-dCT and pcTat at 1 : 1 or 2 : 1 with Magic5A cells, the HIV-1 envelope-mediated cell-cell fusion system has been constructed. The enhancing effect of Th on the fusion has been proven.
出处 《中国地方病学杂志》 CAS CSCD 北大核心 2007年第6期695-698,共4页 Chinese Jouranl of Endemiology
基金 国家自然科学基金项目(30471608) 教育部重点研究项目(206403) 哈尔滨医科大学研究生创新基金
关键词 Ⅰ型人免疫缺陷病毒 HIV-1 包膜糖蛋白 细胞融合 凝血酶 实验体系 Human immunodeficiency virus type Ⅰ Envelope glycoproteins Cell fusion Thrombin
  • 相关文献

参考文献11

  • 1Pierson TC, Doms RW. HIV-1 entry and its inhibition [J]. Curt Top Microbiol Immunol,2003,281 : 1-27.
  • 2Ling H, Xiao P, Usami O, et al. Thrombin activates envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and enhance fusion[J]. Microbes Infect,2004, 6(5): 414-420.
  • 3刘北一,朱平,姜世勃,富宁.合成环肽抑制HIV-1病毒介导的细胞融合的初步研究[J].热带医学杂志,2006,6(8):871-872. 被引量:2
  • 4曾祥凤,曾耀英,李海仙.体外快速筛选抗HIV药物的一种新方法[J].暨南大学学报(自然科学与医学版),2006,27(2):233-238. 被引量:3
  • 5Papandreou M J, Fenouillet E. Effect of changes in the glycosylation of the human immunodeficiency virus type 1 envelope on the immunoreactivity and sensitivity to thrombin of its third variable domain[J]. Virology, 1998,241 ( 1 ) : 163-167.
  • 6Krammer PH. HIV-1 Tat and T cell apoptosis [J ]. Retrovirology. 2006,3 Suppl 1: 43.
  • 7Natarajan V, Radjendirane V, Salzman NP. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells [J ]. Virology, 1993,196(1 ) : 122-129.
  • 8Fukumori T, Kagawa S, Iida S, et al. Rev-dependent expression of three species of HIV-1 mRNAs[J]. Int J Mol Med, 1999,3(3) : 297-302.
  • 9Berlioz-Torrent C, Shacklett BL, Erdtmann L, et al. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins [J ]. J Virol, 1999,73 (2) : 1350-1361.
  • 10Yoon .JS, .lung YT, Hong SK, et al. Characteristics of HIV-Tat protein transduction domain[J].J Microbiol,2004,42(4):328-335.

二级参考文献21

  • 1刘北一,朱平,韩强涛,姜世勃,富宁.HIV-1gp41 C-螺旋模拟位的筛选和鉴定[J].中国免疫学杂志,2004,20(9):633-636. 被引量:2
  • 2[1]GARBER D A,SILVESTRI G,FEINBERG M B.Prospects for an AIDS vaccine:three big questions,no easy answers[J].The Lancet Infectious Diseases,2004,4(7):397 -413.
  • 3[2]ADESOJI A.Education:An antidote for the spread of HIV/AIDS[J].Association of Nurses In AIDS Care,2005,16 (2):40 -48.
  • 4[3]ZAROCOSTASJ.Who puts HIV/AIDS pandemic at top of its agenda[J].Lancet,2004,363(9421):1615.
  • 5[4]RUXUNGTHAM K,BROWN T,PHANUPHAK P.HIV/AIDS in Asia[J].Lancet,2004,364 (9428):69-82.
  • 6[5]WATTS J.China faces up to HIV/AIDS epidemic[J].Lancet,2003,362(9400):1983.
  • 7[6]WALKER N,GRASSLY N C,GARNETr G P,et al.Estimating the global burden of HIV/AIDS:what do we really know about the HIV pandemic?[J].Lancet,2004,363 (9427):2180 -2185.
  • 8[7]AINSWORTH M,TEOKUL W.Breaking the silence:setting realistic priorities for AIDS control in less-de-veloped countries[J].Lancet,2000,356(9223):55 -60.
  • 9[8]TANGJ W,PILLAY D.Transmission of HIV-1 drug resistance[J].JClin Virol,2004,30(1):1 -10.
  • 10[9]JOHNSON M O,CHARLEBOIS E,MORIN S F,et al.Perceived adverse effects of antiretroviral therapy[J].J Pain Symptom Manage,2005,29(2):193 -205.

共引文献3

同被引文献10

  • 1Ling H,Zhang XY,Usami O,et al.Activation of gp120 of human immunodeficiency virus by their V3 loop-derived peptides[J].Biochem Biophys Res Commun,2002,297 (3):625-631.
  • 2Cheng DC,Zhong GC,Su JX,et al.A sensitive HIV-1 envelope induced fusion assay identifies fusion enhancement of thrombin[J].Biochem Biophys Res Commun,2010,391 (4):1780-1784.
  • 3Ji J,Cloyd MW.HIV-1 binding to CD4 on CD4 + CD25 + regulatory T cells enhances their suppressive function and induces them to home to,and accumulate in,peripheral and mucosal lymphoid tissues:an additional mechanism of immunosuppression[J].Int Immunol,2009,21 (3):283-294.
  • 4Puigdomènech I,Massanella M,Izquierdo-Useros N,et al.HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is govemed by the interaction of HIV envelope glycoprotein with CD4[J].Retrovirology,2008,31 (3):32.
  • 5Clements GJ,Price-Jones MJ,Stephens PE,et al.The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites:a possible function in viral fusion[J].AIDS Res Hum Retroviruses,1991,7(1):3-16.
  • 6Avril LE,Martino-Ferrer DM,di Brillard-Bourdet M,et al.Inhibition of U937 membrane-associated cathepsin G by gp120 (ⅢB) and V3 loop-derived peptides from several strains of HIV-1[J].FEBS lett,1995,367 (3):251-256.
  • 7Caly L,Jans DA,Piller SC.Proteolytic cleavage of HIV-1 GFP-Vpr fusions at novel sites within virions and living cells:concerns for intracellular trafficking studies[J].J Fluoresc,2009,19 (3):567-573.
  • 8Johnson ME,Lin Z,Padmanabhan K,et al.Conformational rearrangements required of the V3 loop of HIV-1 gpl20 for proteolytic cleavage and infection[J].FEBS Lett,1994,337(1):4-8.
  • 9Power C,Zhang K,Van Marle G.Comparative neurovirulence in lentiviral infections:The roles of viral molecular diversity and se-lect proteases[J].J Neurovirol,2004,10 suppl 1:113-117.
  • 10Bristow CL,Babayeva MA,LaBrunda M,et al.α1 Proteinase inhibitor regulates CD4 + lymphocyte levels and is rate limiting in HIV-1 disease[J].PLoS One,2012,7(2):e31383.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部